L
Lamictal®
(lamotrigine)

Lamisil Oral Granules®
(terbinafine hydrochloride)

Lanoxin®
(digoxin)

Lantus®
(insulin glargine)

Lasix® Tablets
(furosemide)

Lescol®/Lescol® XL
(fluvastatin sodium)

Leukeran®
(chlorambucil)

Levaquin®*
(levofloxacin)

Levoxyl
(levothyroxine sodium)

Lexiva®
(fosamprenavir calcium)

Lincocin®
(lincomycin hydrochloride)

Lipitor®
(atorvastatin calcium)

Lipitor® 10 mg Tablets Unit-Dose Pak
(atorvastatin calcium)

Lipitor® 20 mg Tablets Unit-Dose Pak
(atorvastatin calcium)

Lipitor® 40 mg Tablets Unit-Dose Pak
(atorvastatin calcium)

Lipitor® 80 mg Tablets Unit-Dose Pak
(atorvastatin calcium)

Lomotil® 2.5 mg/.025 mg Tablets C-V
(diphenoxylate hydrochloride/atropine sulfate)

Lomotil® 2.5 mg/.025 mg 5 mL Liquid C-V
(diphenoxylate hydrochloride/atropine sulfate)

Loniten®
(minoxidil)

Lopid®
(gemfibrozil)

Lovaza™
(omega-3-acid ethyl esters)

Lovenox®
(enoxaparin sodium injection)

Lyrica®
(pregabalin)

Lyrica® 50 mg Capsules Unit-Dose Pak C-V
(pregabalin)

Lyrica® 75 mg Capsules Unit-Dose Pak C-V
(pregabalin)

Lyrica® 100 mg Capsules Unit-Dose Pak C-V
(pregabalin)

Lyrica® 150 mg Capsules Unit-Dose Pak C-V
(pregabalin)

Together Rx Access is a trademark of Together Rx Access, LLC. All other marks are the property of their respective owners.

* Abilify Tablets are manufactured by Otsuka Pharmaceutical Co, Ltd, Tokyo, 101-8535 Japan or Bristol-Myers Squibb Company, Princeton, NJ 08543 USA. Distributed and marketed by Otsuka America Pharmaceutical, Inc, Rockville, MD 20850 USA. Marketed by Bristol-Myers Squibb Company, Princeton, NJ 08543 USA. Avapro and Plavix are distributed by Bristol-Myers Squibb Sanofi-Synthelabo Partnership, New York, NY 10016. LEVAQUIN® is a registered trademark of Daiichi Pharmaceutical, Co. VESIcare® is marketed by Yamanouchi Pharma America, Inc. (to be known as Astellas Pharma US, Inc., as of 4/1/05) and GlaxoSmithKline.

Certain limitations may apply with respect to specific drugs.